Skip to main content

Histopathological Aspects of Dysplastic Nevi

  • Chapter
Cutaneous Melanoma and Precursor Lesions

Part of the book series: Developments in Oncology ((DION,volume 25))

Abstract

A dysplastic nevomelanocytic nevus (DN) can be defined as a localized proliferation of melanocytes with cytological and architectural atypia. Synonyms for DN used in the literature include B-K mole, atypical melanocytic hyperplasia, atypical melanocytic nevus, or atypical melanocytic proliferation (1,2,3,4,5). Originally, the term DN was used for nevi with atypia associated with dermal changes exclusively in patients with the familial DN syndrome (1). More recently, it was recognized that DN may occur in patients with a history of primary cutaneous melanoma (PCM), but without evidence of the familial occurrence of PCM or DN, i.e. sporadic DN syndrome (6). The prevalence of DN in the general population is not known, but is estimated as high as 2 to 8% (7). DN are considered as precursor lesions for PCM, the lifetime risk for patients with the familial DN syndrome may approach 100% (7,8). However, PCM in these patients also may arise “de novo” from ostensibly normal skin (7). As the impact of DN on the incidence of PCM may be considerably, it is important to recognize them clinically and histologically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clark, W.H., Jr. Reimer, R.R., Greene, M.H., Ainsworth, A.M., Mastrangelo, M. J. Origin of familial malignant melanomas from heritable melanocytic lesions. “The B-K Mole syndrome”. Arch.Dermatol. 1978; 114: 732–738.

    Google Scholar 

  2. Lynch, H.T., Frichot, B.C., Lynch, J.F. Multiple mole melanoma syndrome. J.Med.Genet. 1978; 15: 352.

    Article  PubMed  CAS  Google Scholar 

  3. Greene, M.H., Clark, W.H.,Jr. Tucker, M.A., Elder, D.E., Kraemer, K.H., Fraser, M.C., Bondi, E.E., Guerry, D., IV, Tuthill, R.J., Hamilton, R., Larossa, D. Precursor nevi in cutaneous malignant melanoma. A proposed nomenclature. Lancet 1982; 2: 1024.

    Google Scholar 

  4. Rywlin, A.M. Dysplasia.On the terminology of atypical intraepithelial proliferations. Amer.J.Dermatopathol. 1981; 3: 183.

    Article  CAS  Google Scholar 

  5. MacKie, R.M. Multiple melanoma and atypical melanocytic naevi, evidence of an activated and expanded melanocytic system.Br.J.Dermatol. 1982; 107: 621–629.

    CAS  Google Scholar 

  6. Elder, D.E., Goldman, L.I., Goldman, S.C., Greene, M.H., Clark, W.H. Dysplastic nevus syndrome. A phenotypic association of sporadic cutaneous melanoma. Cancer 1980; 46: 1787–1794.

    Article  PubMed  CAS  Google Scholar 

  7. Freinkel, R.K., a.o. Precursors to malignant melanoma. National Institutes of Health Concensus Development Conference Summary. 1983; 4: Number 9.

    Google Scholar 

  8. Kraemer, K.H., Greene, M.H., Tarone, R., Elder, D.E., Clark, W.H. Jr. Guerry, D.,IV. Dysplastic naevi and cutaneous melanoma risk. Lancet 1983; 2: 1076–1077.

    CAS  Google Scholar 

  9. Elder, D.E., Greene, M.H., Bondi, E.E., Clark, W.H.,Jr. Acquired melanocytic nevi and melanoma. In: Pathology of malignant melanoma. A.B. Ackerman, Ed. Masson Publishing, New York 1981.

    Google Scholar 

  10. Lever, WF., Schaumberg-Lever, G. Histopathology of the Skin. Lippincott 6th ed. Philadelphia 1983.

    Google Scholar 

  11. Reed, R.J., Clark, W.H.,Jr. Mihm, M.C.,Jr. Premalignant melanocytic dysplasia. In: Pathology of malignant melanoma, A.B. Ackerman, Ed. Masson Publishing, NewYork. 1981; 129–157.

    Google Scholar 

  12. Rhodes, A.R., Harrist, T.J., Day, C.L., Mihm, M.C.Jr. Fitzpatrick, T.B., Sober, A.J. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J. Amer. Acad. Dermatol. 1983; 9: 563–574.

    Article  CAS  Google Scholar 

  13. Bergman, w., Ruiter, D.J., Scheffer, E., Van Vloten, W.A. Histopathological, immunohistochemical and cytofotometrical characterization of dysplastic nevi. J.Invest.Dermatol., in press, (abstract)

    Google Scholar 

  14. Ruiter, D.J., Bhan, A.K., Harrist, T.J., Sober, A.J., Mihm, M.C. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J.Immunol. 1982; 129: 2808–2815.

    PubMed  CAS  Google Scholar 

  15. Elder, D.E., Kraemer, K.H., Greene, M.H., Clark, W.H. Jr., Guerry, D., IV. The dysplastic nevus syndrome. Our definition. Amer. J. Dermapathol. 1982; 4: 455–460.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Ruiter, D.J., Bergman, W., Steylen, P.M., Scheffer, E. (1984). Histopathological Aspects of Dysplastic Nevi. In: Ruiter, D.J., Welvaart, K., Ferrone, S. (eds) Cutaneous Melanoma and Precursor Lesions. Developments in Oncology, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6057-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6057-2_18

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6059-6

  • Online ISBN: 978-94-009-6057-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics